Development of ferret reagents for use in the characterization of immune responses to respiratory infections in the ferret model.
Ended Definitive Contract Awarded Last action
- Contract number
- 75N93020C00022
- Awardee
-
Ampersand Biosciences LLC UEI HLWQXLFM7JR8
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $572,817
Award facts
- Opportunity
-
- PHS202001 Solicitation number
- Contract value 100% obligated
- $572,817.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- Total Small Business
- Competition
- Full and Open Competition after exclusion of sources · 5 offers Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- UPPER ST REG, NY 12945, USA
- Research
- SBIR Program Phase I Action
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Close Out | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Original award | $572,817 |
About this award
Ampersand Biosciences LLC has been awarded a $572,817 firm fixed price contract by the National Institutes of Health's National Institute of Allergy and Infectious Diseases to develop ferret reagents for use in characterizing immune responses to respiratory infections in the ferret disease model. The contract is associated with the Small Business Innovation Research Program Phase I solicitation and will support the prime contractor's work through August 2022. The total award has been set aside for small businesses. Development of these reagents will provide researchers with additional tools to study respiratory pathogens like influenza using the ferret model, advancing the NIH's efforts to understand and prevent infectious diseases.
Quick answers
Who was awarded contract 75N93020C00022?
75N93020C00022 was awarded to Ampersand Biosciences LLC by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on July 1, 2020.
How much is contract 75N93020C00022 worth?
The government has obligated $572,817 on 75N93020C00022.
Was contract 75N93020C00022 competed?
The extent of competition for 75N93020C00022 was full and open competition after exclusion of sources. The government received 5 offers. It was set aside: Total Small Business.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award